CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Assets
Cash and cash equivalents	$ 439.5	$ 430.8
Receivables	433.8	383.3
Investments in marketable securities	77.8	122.4
Other investments	165.0	147.5
Fixed assets (net)	111.0	110.1
Goodwill	2,662.5	2,628.1
Acquired client relationships (net)	1,449.7	1,497.4
Equity method investments in Affiliates	3,304.7	3,368.3
Other assets	58.1	61.2
Total assets	8,702.1	8,749.1
Liabilities and Equity
Payables and accrued liabilities	807.2	729.3
Senior bank debt	809.0	868.6
Senior notes	741.3	939.4
Convertible securities	304.4	301.6
Deferred income tax liability (net)	467.4	660.8
Other liabilities	182.4	149.4
Total liabilities	3,311.7	3,649.1
Commitments and contingencies
Redeemable non-controlling interests	811.9	673.5
Equity:
Common stock ($0.01 par value, 153.0 shares authorized; 58.5 shares outstanding in 2016 and 2017)	0.6	0.6
Additional paid-in capital	808.6	1,073.5
Accumulated other comprehensive loss	(21.8)	(122.9)
Retained earnings	3,698.5	3,054.4
Total stockholders' equity before treasury stock	4,485.9	4,005.6
Less: Treasury stock, at cost (1.8 shares in 2016 and 3.4 shares in 2017)	(663.7)	(386.0)
Total stockholders’ equity	3,822.2	3,619.6
Non-controlling interests	756.3	806.9
Total equity	4,578.5	4,426.5
Total liabilities and equity	$ 8,702.1	$ 8,749.1

Accumulated change in equity applicable to the parent entity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

No definition available.